About TBC1 domain family member 8
TBC1 domain family member 8 (TBC1D8) is a protein
from Homo sapiens identified by UniProt accession
O95759, 1140 residues long.
MolForge cross-references it against 0 known binders and
179 disease associations.
Target properties
| Protein name | TBC1 domain family member 8 |
| UniProt accession | O95759 |
| Gene | TBC1D8 |
| Organism | Homo sapiens |
| Length | 1140 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (179)
Diseases linked to this target (Open Targets).
- neutrophil count · score 0.45
- leukocyte count · score 0.43
- myeloid white cell count · score 0.42
- reticulocyte count · score 0.35
- reticulocyte measurement · score 0.35
- lymphocyte percentage of leukocytes · score 0.34
- neutrophil percentage of leukocytes · score 0.34
- smoking status measurement · score 0.31
- carotid artery intima media thickness · score 0.31
- creatinine measurement · score 0.29
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-O95759-F1 | alphafold | PREDICTED | 78.46 | — |
Amino-acid sequence (1140 residues)
MWLKPEEVLL KNALKLWVTQ KSSCYFILQR RRGHGEGGGR LTGRLVGALD AVLDSNARVA PFRILLQVPG SQVYSPIACG ATLEEINQHW DWLEQNLLHT LSVFDNKDDI ASFVKGKVKA LIAEETSSRL AEQEEEPEKF REALVKFEAR FNFPEAEKLV TYYSCCCWKG RVPRQGWLYL SINHLCFYSF FLGKELKLVV PWVDIQKLER TSNVFLTDTI RITTQNKERD FSMFLNLDEV FKVMEQLADV TLRRLLDNEV FDLDPDLQEP SQITKRDLEA RAQNEFFRAF FRLPRKEKLH AVVDCSLWTP FSRCHTTGRM FASDSYICFA SREDGCCKII LPLREVVSIE KMEDTSLLPH PIIVSIRSKV AFQFIELRDR DSLVEALLAR LKQVHANHPV HYDTSADDDM ASLVFHSTSM CSDHRFGDLE MMSSQNSEES EKEKSPLMHP DALVTAFQQS GSQSPDSRMS REQIKISLWN DHFVEYGRTV CMFRTEKIRK LVAMGIPESL RGRLWLLFSD AVTDLASHPG YYGNLVEESL GKCCLVTEEI ERDLHRSLPE HPAFQNETGI AALRRVLTAY AHRNPKIGYC QSMNILTSVL LLYTKEEEAF WLLVAVCERM LPDYFNHRVI GAQVDQSVFE ELIKGHLPEL AEHMNDLSAL ASVSLSWFLT LFLSIMPLES AVNVVDCFFY DGIKAIFQLG LAVLEANAED LCSSKDDGQA LMILSRFLDH IKNEDSPGPP VGSHHAFFSD DQEPYPVTDI SDLIRDSYEK FGDQSVEQIE HLRYKHRIRV LQGHEDTTKQ NVLRVVIPEV SILPEDLEEL YDLFKREHMM SCYWEQPRPM ASRHDPSRPY AEQYRIDARQ FAHLFQLVSP WTCGAHTEIL AERTFRLLDD NMDQLIEFKA FVSCLDIMYN GEMNEKIKLL YRLHIPPALT ENDRDSQSPL RNPLLSTSRP LVFGKPNGDA VDYQKQLKQM IKDLAKEKDK TEKELPKMSQ REFIQFCKTL YSMFHEDPEE NDLYQAIATV TTLLLQIGEV GQRGSSSGSC SQECGEELRA SAPSPEDSVF ADTGKTPQDS QAFPEAAERD WTVSLEHILA SLLTEQSLVN FFEKPLDMKS KLENAKINQY NLKTFEMSHQ SQSELKLSNL
Explore TBC1 domain family member 8 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets